Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Elena Goryunova"'
Autor:
Elena Goryunova, Bill McKelvey
Publikováno v:
Management in the Age of Digital Business Complexity ISBN: 9780429278211
Ethical conflicts underlying business and society tensions threaten sustainability of our global society. The purpose of this chapter is to present a new epistemological framework of complexity science and recent advances in moral neurosciences in or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::433adb2eebff130ffcf5159e5e9eaf7e
https://doi.org/10.4324/9780429278211-6
https://doi.org/10.4324/9780429278211-6
Autor:
Elena Goryunova, Natalia Malishevskaya, Liliya Alexandrovna Lazareva, Tatiana Isaeva, Mikhail Churikov
Publikováno v:
E3S Web of Conferences, Vol 273, p 12011 (2021)
During the period of COVID-19 pandemic when mostly all the universities have transferred to distant learning, the educational effect of many interactive methods partially reduced. However, simulation is underestimated by university professors and sca
Autor:
Tatiana Isaeva, Elena Goryunova
Publikováno v:
E3S Web of Conferences, Vol 273, p 12147 (2021)
The organization of professional communication in the context of e-learning is unthinkable without solving a number of issues related to the university teachers’ speech behaviour. During the COVID-19 pandemic, the problem of studying of the teacher
Autor:
Irina Vladimirovna Savchenko, Olga Bessarabova, Tatiana Isaeva, Elena Goryunova, Elmira Shefieva
Publikováno v:
Indian Journal of Science and Technology. 9
This article presents an analysis of the system of engineering education in general and railway engineering training, particularly in the USA, Great Britain, Australia and Singapore. These countries were chosen to be the most advanced in the sphere o
Autor:
Elena Goryunova
Publikováno v:
Academy of Management Proceedings. 2015:16492
Autor:
Elena Goryunova
Publikováno v:
Academy of Management Proceedings. 2013:13460
The triumph of capitalism over the globe has demonstrated both its wealth-creating power and its ever-increasing threat to sustainability of human society. In order to address ever-increasing socie...
Autor:
Elena Goryunova
Publikováno v:
Academy of Management Proceedings. 2013:12876
The current context of global knowledge economy has brought research attention to the role of organizational innovation for sustainable value creation. The Nahapiet and Ghoshal's (1998)seminal work...
Autor:
Elena Goryunova, Larisa Girshova, Ekaterina Romanova, Yulia Alexeeva, Tatiana Nikulina, Dmitry Motorin, Andrey Zaritskey
Publikováno v:
Blood. 118:4286-4286
Abstract 4286 AML M-4 with >30% bone marrow myeloblasts was detected in 63 y old woman 2 mo after a diagnosis of chronic myelomonocytic leukemia (CMMLgrade 2). Cytogenetics showed 46, XX, del(5)(q12 q14) (N=4)/46, XX (N=18). Immune-phenotyping sho
Autor:
Elena Koryagina, Irina Zotova, Elza Lomaia, Natalia Ilina, Vasiliy Shuvaev, Andrey Zaritskey, Zvenyslava Masliak, Irina Dyagil, Natalia Lazorko, Natalia Babkina, Irina Dmitrenko, T. Perekhrestenko, Elena Machulaitene, Svetlana Stepanova, Ekaterina Poznyak, Elena Usacheva, Kudrat Abdulkadirov, Irina Martinkevich, Eugenia Sbityakova, Ekaterina Romanova, Alla Abdulkadirova, Elena Goryunova, Maria Ivanova, Vera Udalieva, Tatiana Shneider
Publikováno v:
Blood. 118:4452-4452
Abstract 4452 Imatinib (IM) is now used world-wide as a first line chronic myeloid leukemia (CML) treatment. Although some time lack may exist between diagnosis and IM treatment. Earlier (Blood 2009, 114: Abstract 4278) we have shown that in CML chro
Autor:
Elena Usacheva, Vasiliy Shuvaev, Elena Goryunova, Svetlana Stepanova, Ekaterina Romanova, Kudrat Abdulkadirov, Alla Abdulkadirova, Tatiana Shneider, Irina Zotova, Elena Machulaitene, Andrey Zaritskey, Ekaterina Poznyak, Eugenia Salamatova, Vera Udalieva, Elza Lomaia, Elena Koryagina, Irina Martinkevich, Natalia Ilina, Natalija Lazorko
Publikováno v:
Blood. 114:4288-4288
Abstract 4288 Resistance to imatinib could be overcome by new generations of TKIs. Data about the efficacy of second line TKI treatment may help to create a system for prognosing the duration of 2nd line TKI treatment and time of switching from secon